- Home
- RTO vs PEN Comparison
RTO vs PEN Comparison
Compare RTO & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RTO
- PEN
- Stock Information
- Founded
- RTO 1925
- PEN 2004
- Country
- RTO United Kingdom
- PEN United States
- Employees
- RTO N/A
- PEN N/A
- Industry
- RTO Business Services
- PEN Medical/Dental Instruments
- Sector
- RTO Consumer Discretionary
- PEN Health Care
- Exchange
- RTO Nasdaq
- PEN Nasdaq
- Market Cap
- RTO 12.0B
- PEN 9.7B
- IPO Year
- RTO N/A
- PEN 2015
- Fundamental
- Price
- RTO $27.40
- PEN $266.29
- Analyst Decision
- RTO Buy
- PEN Strong Buy
- Analyst Count
- RTO 1
- PEN 16
- Target Price
- RTO N/A
- PEN $307.19
- AVG Volume (30 Days)
- RTO 894.9K
- PEN 447.8K
- Earning Date
- RTO 07-31-2025
- PEN 11-05-2025
- Dividend Yield
- RTO 1.88%
- PEN N/A
- EPS Growth
- RTO N/A
- PEN 367.34
- EPS
- RTO 0.13
- PEN 4.14
- Revenue
- RTO $7,581,860,530.00
- PEN $1,333,798,000.00
- Revenue This Year
- RTO $45.27
- PEN $15.52
- Revenue Next Year
- RTO $3.22
- PEN $14.20
- P/E Ratio
- RTO $40.24
- PEN $65.00
- Revenue Growth
- RTO N/A
- PEN 14.61
- 52 Week Low
- RTO $19.60
- PEN $221.26
- 52 Week High
- RTO $30.10
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- RTO 53.43
- PEN 63.41
- Support Level
- RTO $26.82
- PEN $225.52
- Resistance Level
- RTO $27.71
- PEN $272.00
- Average True Range (ATR)
- RTO 0.50
- PEN 9.15
- MACD
- RTO -0.19
- PEN 3.50
- Stochastic Oscillator
- RTO 21.19
- PEN 96.35
About RTO Rentokil Initial plc
Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in 89 countries. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.